
Bio-pharma industry, albeit slow in adopting digital intervention, is now opening up to new-age automation technologies, Kaushik told Financial Express.com.
According to the company, it is developing the proposed tocilizumab biosimilar as both subcutaneous and intravenous formulations.
Some Biosimilar products help in increasing neutrophil counts of cancer patients, which helps to boost the immune system and reduce…
Rymti is a biosimilar of Etanercept which is an injectable, biologic medicine that inhibits Tumour Necrosis Factor (TNF)
The company stated that following the completion of the clinical trial and receipt of marketing authorization from PMDA in Japan,…
The acquisition of biosimilars assets of Viatris significantly strengthens BBL’s position in providing affordable access to patients through its portfolio…
TR-Pharm will manufacture the drug substance and drug product upon completion of its facility investment in Turkey
Supported by acquisitions, geographic expansion and steadily expanding product portfolio, the top-10 pharma companies from India have achieved a CAGR…
Ranibizumab is indicated for the treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD), a common degenerative condition of the eyes…
Offer allows Biocon to monetise its shareholding in Syngene